Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Giovanni Luigi Di Maria Added: 2 years ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more
Author(s): Nazli Okumus , Jeffrey L Carson Added: 2 years ago
AHA 2023 — Investigator, Dr Jeffrey Carson (Rutgers University, US) joined Dr Nazli Okumus, CardioNerds Ambassador to discuss findings from the MINT trial (NCT02981407).The aim of this randomised, parallel assignment trial (Rutgers) is to compare liberal and restrictive red blood cell transfusion strategies in patients who have had an acute myocardial infarction (AMI) and are anemic… View more
Job title: Cardiology Registrar and NIHR Clinical Lecturer
Clinical academic cardiologist with specialist interest in valvular heart disease, heart failure and multimodality imaging. BHF Intermediate Clinical Research Fellow and Senior Lecturer in Cardiology at UCL; Honorary Consultant Cardiologist at Barts Health . Investigates myocardial fibrosis in aortic stenosis using cardiovascular magnetic resonance, cardiac CT and myocardial biopsies. Current… View more
Added: 1 year ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary… View more
Start date: Jun 24, 2024 End date: Jun 25, 2024
The conference is in production. If you would like to speak at this meeting contactlauren@globalengage.co.uk. NAFLD/MASLD continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing ourunderstanding of the disease’s mechanisms. Developments innon-invasivediagnostic biomarkerscontinue to offer the hope… View more